MYC and familial pancreatic carcinoma: C-Myc contributes to tumor angiogenesis, metastasis, and chemoresistance; C-Myc overexpression is associated with chemoresistance, intra-tumor angiogenesis, epithelial–mesenchymal transition (EMT), and metastasis in pancreatic cancer [85].